Science funding is being recast as a lever of power
- Editorial Team SDG9
- 11 hours ago
- 6 min read
Published on 12 April 2026 at 03:22 GMT
By Editorial Team SDG9
Science funding in Asia is being reshaped by a new political calculation. Research is no longer treated chiefly as a long-term public good or a prestige project for elite universities. It is increasingly being organised as strategic infrastructure, tied to industrial policy, talent competition, supply-chain resilience, economic security and diplomatic influence. Across the region, governments are spending more selectively, philanthropy is moving closer to state priorities, and laboratories are being asked to produce both discovery and advantage. Science is now part of statecraft.
The shift is visible in the language of policy. In Singapore, the long-running research framework has evolved from support for science and engineering into a system explicitly built around “research, innovation and enterprise”, with commercialisation, entrepreneurship and white-space strategic spending embedded in five-year plans. In January 2026, the government announced a further S$1 billion for public AI research from 2025 to 2030, focused on fundamental AI, applied AI and talent development. Public research is being directed towards strategic technologies.
The same logic runs through other Asian systems, although with different political styles. In South Korea, the Ministry of Science and ICT said its 2025 and 2026 budgets would prioritise AI, semiconductors, biotechnology, quantum technology and a more “pioneering” R&D model, while also restoring support for basic research and regional innovation after earlier cuts. The 2026 national R&D budget was finalised at KRW 35.5 trillion, with a strong emphasis on AI transformation and next-generation strategic technologies. Budgets are being written with competition in mind.
In Japan, the official strategy is similarly explicit. The Cabinet Office’s Integrated Innovation Strategy links science policy to critical technologies, AI competitiveness, research security and economic resilience. Government documents also underline the scale of private-sector participation, noting that companies account for roughly 70 per cent of total national R&D investment. That is a reminder that strategic science policy in Asia is not simply about more state money. It is about aligning public and private capital behind nationally significant technological goals. The dividing line between science policy and industrial policy is fading.
Nowhere is the strategic turn more consequential than in China. Nature reported in December 2025 that China accounted for more than half of leading output in the applied sciences in the first Nature Index ranking for that category, underscoring how rapidly the country has converted sustained investment into globally visible research strength. A companion Nature analysis published in March 2026 argued that China is looking to maintain its pace through a pivot towards additional sources of funding and collaboration, including philanthropy and public-private initiatives. China has made research output a measure of national strength.
That brings philanthropy into sharper focus. The older model of Asian philanthropy often centred on scholarships, buildings, hospitals or disaster response. What is changing is the move into frontier research itself. Nature’s March 2026 reporting on China described increased donations, prizes and public-private initiatives tied to research, suggesting that major firms and wealthy donors want to signal alignment with government priorities while helping build scientific prestige. This does not make philanthropy irrelevant or purely instrumental. It does, however, mean that private giving is increasingly operating inside a national strategic frame rather than outside it. Philanthropy is no longer sitting at the margins of research policy.
India is pursuing a related, but distinct, route. The Anusandhan National Research Foundation, or ANRF, has been designed not only to widen research participation beyond a narrow set of elite institutions but also to mobilise substantial non-government resources. Indian government statements in 2025 said the ANRF structure envisages ₹50,000 crore over five years, with ₹36,000 crore expected from non-governmental sources, and officials have repeatedly framed philanthropy, industry and translation to market as central to a “self-sustainable” research ecosystem. In February 2026 the first RDI Fund call under the ANRF framework was launched to support commercialisation of indigenous technologies through long-term financing. India is trying to crowd private money into public research goals.
That strategy has already produced visible partnerships. In 2025, the Wadhwani Foundation, a non-profit active in entrepreneurship and innovation, entered into high-profile agreements around research translation with the ANRF, while a separate initiative linked IIT Bombay and the foundation in a joint healthcare and medicine hub. These arrangements matter because they show how philanthropic or non-profit capital is being positioned as a bridge between laboratory research, industrial uptake and national technology agendas. They also show the political appeal of private money that can move faster than ministries but still reinforce state priorities. Translation is becoming as important as discovery.
There are practical reasons for this convergence. Strategic technologies are expensive, talent is mobile, and the returns from basic science are uncertain and slow. Governments want leverage, not just spending. Philanthropic capital can tolerate early-stage risk, fund prizes, support shared facilities or seed interdisciplinary work. The OECD said in its 2026 review that philanthropic contributions to development totalled USD 68.2 billion between 2020 and 2023, with domestic philanthropy in middle-income countries expanding, albeit unevenly. That matters in Asia because several governments are trying to build precisely those domestic philanthropic and quasi-philanthropic ecosystems that can co-finance ambitious research missions. Flexible capital is gaining political value.
Yet the strategic remaking of science funding also raises uncomfortable questions. When governments define priority sectors too tightly, there is a risk that research ecosystems become narrower, more instrumental and less tolerant of curiosity-driven inquiry. South Korea’s own budget language, for instance, tries to balance strategic investment with support for basic research. Japan’s planning documents likewise stress the need to strengthen research capabilities and knowledge bases, not merely commercial outcomes. Those caveats are important, because countries that over-optimise for near-term geopolitical or industrial pay-offs can weaken the broader foundations that make innovation possible in the first place. Basic research still matters, even in a strategic age.
There is a second tension, and it is not financial but civic. If science becomes a strategic asset, states may become more protective of data, partnerships and cross-border collaboration. Research security rules can be justified, especially in fields with military or dual-use implications. But they can also chill openness, reduce international exchange and make scholars more cautious. That is why organisations such as Scholars at Risk matter to the discussion. In 2025, the group highlighted the launch of the Southeast Asian Coalition for Academic Freedom, intended to strengthen protections, monitoring and solidarity across the region. Academic freedom is part of research capacity.
Open science is another fault line. If research is increasingly linked to competition, who gets to access data, publications and shared infrastructure? Wellcome, one of the world’s most influential charitable research funders, tightened its open-access requirements from January 2025, funding article processing charges only for fully open-access journals or platforms indexed in the Directory of Open Access Journals. Meanwhile, UNESCO has continued to push open science in Asia and the Pacific through regional webinars and implementation work linked to its recommendation on open science. These are not minor procedural issues. They shape whether publicly useful knowledge circulates widely or is enclosed within strategic blocs. Openness and sovereignty are in growing tension.
For the public, the stakes are larger than rankings or patents. The way science is funded will influence whose problems get researched, which regions receive laboratories and talent programmes, whether universities retain intellectual autonomy, and how quickly useful innovations reach health systems, energy networks and climate adaptation efforts. The agenda connects most directly to SDG 9, industry, innovation and infrastructure, but also to SDG 4, quality education, SDG 16, strong institutions, and SDG 17, partnerships for the goals. Those links are not rhetorical. They reflect a real policy question: whether Asia’s new science compact can remain socially broad, or whether it will narrow into a race for technological advantage alone.
The most likely outcome is neither a simple boom nor a straightforward capture of science by the state. Asia is building a hybrid model. Governments will remain the largest architects of direction, but philanthropy, non-profits, corporate money and university-industry platforms will play a bigger role in choosing what gets accelerated. The result could be more resilient, better financed research ecosystems. It could also produce greater concentration, more political steering and sharper inequalities between fashionable fields and neglected ones. The region’s central experiment is now clear. Asia is turning research into infrastructure for power, prosperity and influence.
Further information:
· ANRF, India’s national research foundation is central to the country’s effort to blend public research funding with private and philanthropic capital.
· Wadhwani Foundation, a non-profit partner in India’s research translation push, is helping finance innovation hubs and industry-facing programmes. https://wadhwanifoundation.org
· Wellcome, a major global charitable funder of research, is relevant for its grantmaking and open-access rules affecting work in Asia. https://wellcome.org
· Scholars at Risk, a civil society network focused on threatened scholars and academic freedom, is relevant as research security and political pressure grow. https://www.scholarsatrisk.org
· UNESCO, while not an NGO, is a key multilateral source on open science and SDG-linked research policy in Asia and the Pacific.
